Form 4: Rhythm Pharmaceuticals Executive Yann Mazabraud Sells 16,000 Shares to Cover Tax Obligations

EVP, Head of International at Rhythm Pharmaceuticals, Yann Mazabraud, sold 16,000 shares of common stock on March 19, 2024, to cover withholding taxes related to vesting restricted stock units.

Summary

• On March 19, 2024, Yann Mazabraud, EVP, Head of International at Rhythm Pharmaceuticals, sold 16,000 shares of common stock.
• The sale was executed at a weighted average price of $39.22 per share, with individual transactions ranging from $39.10 to $39.22.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted before February 27, 2023.
• The purpose of the sale was to cover withholding taxes associated with the vesting of previously reported restricted stock units.
• Following the transaction, Mazabraud directly owns 24,495 shares of Rhythm Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be a routine sale to cover tax obligations, executed under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Insider sales are a common occurrence, especially when tied to tax obligations related to equity compensation. The use of a pre-arranged Rule 10b5-1 trading plan suggests the sale was planned and not based on current market conditions or inside information.

Stakeholder Impact

• The sale could have a minor negative impact on shareholder sentiment, although it is likely to be minimal given the context of the transaction.

Key Dates